- $2.61bn
- $2.93bn
- $557.57m
U.S. RESEARCH ROUNDUP-Bankunited, Eqrx, Syneos Health
Brief: Gcm Grosvenor Reports Fourth Quarter And Full Year 2021 Results
Brief: Gcm Grosvenor Makes Majority Investment In Resource Waste Services
Brief: GCM Grosvenor Reports Q3 Revenue Of $118.1 Million
Brief: GCM Grosvenor Raises $500 Mln
Brief: GCM Grosvenor Opens Office in Germany; Hires Markus Koch as Executive Director
U.S. RESEARCH ROUNDUP- Abcellera Biologics, Linde, Spire
Brief: GCM Grosvenor Reports Q2 Results
Brief: GCM Grosvenor Says Exercised Option To Purchase Interest In Mosaic Held By Third-Party Investor
Brief: Gcm Grosvenor Added To Russell 2000 Index
U.S. RESEARCH ROUNDUP-Eli Lilly, Physicians Realty Trust, Welltower
Brief: Gcm Grosvenor Announces $85 Million Upsizing Of Term Loan To Enable Repurchase Of Mosaic Assets
Brief: GCM Grosvenor - Q1 Revenue Up 25% At $103.2 Mln
Brief: GCM Grosvenor Says Grosvenor Capital Management Holdings And Others Entered Into A Fifth Amendment To Credit Agreement Dated Jan 2, 2014
Brief: GCM Grosvenor To Increase Quarterly Dividend Beginning In Q2
U.S. RESEARCH ROUNDUP- GCM Grosvenor, HCA Healthcare, Michaels Companies
Brief: Alaska Communications Announces Entry Into Amended And Restated Merger Agreement With Macquarie Capital And GCM Grosvenor To Increase Consideration To $3.20 Per Share
Brief: GCM Grosvenor Reports Q3 Total Operating Rev of $90.1 Mln Vs $101.7 Mln Q-O-Q
NASDAQ RESUMED AT 12:50 PM